Getein Biotech, Inc (603387.SS)
CNY 7.94
(1.4%)
CNY 7.94
(1.4%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 279.77 Million CNY | -43.92% |
| 2022 | 498.9 Million CNY | 25.04% |
| 2021 | 398.99 Million CNY | 30.93% |
| 2020 | 304.73 Million CNY | -10.29% |
| 2019 | 339.67 Million CNY | 36.08% |
| 2018 | 249.61 Million CNY | 28.67% |
| 2017 | 193.98 Million CNY | 40.21% |
| 2016 | 138.35 Million CNY | 31.68% |
| 2015 | 105.06 Million CNY | 39.84% |
| 2014 | 75.13 Million CNY | 14.49% |
| 2013 | 65.62 Million CNY | 198.85% |
| 2012 | 21.96 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 55.47 Million CNY | -8.75% |
| 2024 Q1 | 86.01 Million CNY | 69.65% |
| 2024 Q2 | 60.79 Million CNY | -29.32% |
| 2023 FY | 279.77 Million CNY | -43.92% |
| 2023 Q3 | 60.34 Million CNY | 27.87% |
| 2023 Q4 | 50.7 Million CNY | -15.99% |
| 2023 Q1 | 121.52 Million CNY | 412.58% |
| 2023 Q2 | 47.19 Million CNY | -61.17% |
| 2022 Q1 | 218.72 Million CNY | 49.94% |
| 2022 FY | 498.9 Million CNY | 25.04% |
| 2022 Q3 | 145.39 Million CNY | 30.9% |
| 2022 Q2 | 111.08 Million CNY | -49.21% |
| 2022 Q4 | 23.7 Million CNY | -83.69% |
| 2021 Q3 | 82.25 Million CNY | -23.97% |
| 2021 Q2 | 108.19 Million CNY | 72.67% |
| 2021 FY | 398.99 Million CNY | 30.93% |
| 2021 Q1 | 62.66 Million CNY | -41.77% |
| 2021 Q4 | 145.87 Million CNY | 77.34% |
| 2020 Q2 | 52.69 Million CNY | 21.85% |
| 2020 Q4 | 107.61 Million CNY | 6.35% |
| 2020 FY | 304.73 Million CNY | -10.29% |
| 2020 Q1 | 43.24 Million CNY | -69.29% |
| 2020 Q3 | 101.18 Million CNY | 92.01% |
| 2019 Q2 | 68.85 Million CNY | -18.99% |
| 2019 Q4 | 140.8 Million CNY | 212.8% |
| 2019 FY | 339.67 Million CNY | 36.08% |
| 2019 Q3 | 45.01 Million CNY | -34.62% |
| 2019 Q1 | 84.99 Million CNY | 22.51% |
| 2018 Q1 | 66.53 Million CNY | 18.8% |
| 2018 FY | 249.61 Million CNY | 28.67% |
| 2018 Q4 | 69.37 Million CNY | 39.65% |
| 2018 Q3 | 49.68 Million CNY | -22.39% |
| 2018 Q2 | 64.01 Million CNY | -3.79% |
| 2017 Q1 | 40.89 Million CNY | -3.4% |
| 2017 Q2 | 48.7 Million CNY | 19.08% |
| 2017 Q3 | 48.38 Million CNY | -0.65% |
| 2017 Q4 | 56 Million CNY | 15.75% |
| 2017 FY | 193.98 Million CNY | 40.21% |
| 2016 Q3 | 33.14 Million CNY | -3.69% |
| 2016 Q1 | 28.46 Million CNY | 0.0% |
| 2016 Q2 | 34.41 Million CNY | 20.91% |
| 2016 Q4 | 42.33 Million CNY | 27.73% |
| 2016 FY | 138.35 Million CNY | 31.68% |
| 2015 Q1 | 21.49 Million CNY | 0.0% |
| 2015 FY | 105.06 Million CNY | 39.84% |
| 2014 FY | 75.13 Million CNY | 14.49% |
| 2013 FY | 65.62 Million CNY | 198.85% |
| 2012 FY | 21.96 Million CNY | 0.0% |